Comparison of PSOX (paclitaxel, oxaliplatin, S-1) and SOX (oxaliplatin, S-1) as postoperative adjuvant chemotherapy for stage II-III gastric cancer

Abstract Background Adjuvant chemotherapy is the conventional treatment for stage II and III gastric cancer(GC). Postoperative doublet chemotherapy has consistently shown improved survival outcomes in advanced-stage GC patients compared to single-agent regimens. Triplet regimens have shown significa...

Full description

Saved in:
Bibliographic Details
Main Authors: Fei-Yu Wang, Xiang-Ming Huang, Yu-Qing Cao, Jie Cao, Meng Song, Zhi-Jun Fang, Xin-En Huang
Format: Article
Language:English
Published: BMC 2025-03-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-025-03723-3
Tags: Add Tag
No Tags, Be the first to tag this record!